logo enJosep Carreras Leukaemia Research Institute

  • CatalàCA
  • EspañolES
  • EnglishEN
  • عربي

Main navigation

  • About Us
    • Who we are
      • Welcome
      • Scientific Founding Members
      • Director
      • Mission, Vision and Values
      • Governing bodies
        • Organizational chart
        • Board of Trustees
        • Management Committee
        • Internal Scientific Committee
        • Scientific Advisory Board (SAB)
        • Campus Coordinators
      • Why a Research Institute focusing on Leukaemia & other malignant blood diseases?
    • Directory
    • Research publications
    • How to find us
      • IJC Campus Clinic-UB
      • Campus ICO-Germans Trias i Pujol
      • Campus Sant Pau
    • Events Calendar
      • Showcasing Discoveries: Open Lectures of its Group Leaders
    • Contractors
    • Josep Carreras International Leukaemia Foundation
    • News & Press
      • News
    • Transparency Portal
    • HR Excellence
  • Research Groups
    • Cancer and Leukemia Epigenetics and Biology Program PEBCL
      • Cancer epigenetics - Manel Esteller
      • Cancer genetics - Montse Sanchez-Cespedes
      • Chromatin biology laboratory - Alex Vaquero
      • Chromatin, metabolism and cell fate - Marcus Buschbeck
      • 3D chromatin organization - Biola M Javierre
      • Epigenetics and immune disease - Esteban Ballestar
      • Lymphocyte development and disease - Maribel Parra
      • Regulatory genomics - Tanya Vavouri
      • Regulatory RNA and chromatin - Sonia Guil
      • Epigenetic control of haematopoiesis - José Luis Sardina
      • Transcriptional dynamics in leukemia - Sergi Cuartero
      • Cancer immunogenomics - Eduard Porta
      • Cancer heterogeneity and hierarchies - Verónica Rodilla
      • Leukemia and immuno-oncology - Laura Belver
      • Cellular systems genomics - Elisabetta Mereu
      • Stem cells and cancer - Anna Bigas
      • Endothelial pathobiology and microenvironment - Mariona Graupera
      • T cell lymphoma - Laura Mondragón
      • Nuclear Architecture in Leukemia - Gregoire Stik
      • Cancer Metabolism - Lucas Pontel
    • Experimental and Clinical Hematology Program PHEC
      • Acute lymphoblastic leukemia (ALL) - José María Ribera
      • Barcelona Endothelium Team (BET) - Enric Carreras
      • Myeloid neoplasms - Lurdes Zamora
      • Immunohematology and glycobiology - Fumiichiro Yamamoto
      • Lymphoid neoplasms - Tomás Navarro
      • Multiple myeloma - Albert Oriol
      • Myelodysplastic syndromes - Francesc Solé
      • Stem cell biology, developmental leukemia and immunotherapy - Pablo Menéndez
      • Stem cell transplantation and cellular Immunotherapy - Álvaro Urbano-Ispizua
      • Epigenetic therapies - María Berdasco
      • Lymphoma translational group - Gaël Roué
      • Oncogenesis and antitumor drugs - Ramon Mangues
      • Chronic lymphocytic leukemia - Carolina Moreno
      • Hematological diseases, transplant, and cell therapy - Jordi Sierra
      • Myeloid neoplasms - Clínic - Jordi Esteve Reyner
      • Hematology - David Gallardo
      • Descriptive epidemiology, genetics and cancer prevention - Rafael Marcos-Gragera
      • Cellular immunotherapy and gene therapy group - Javier Briones
      • Hematological diagnosis - Josep Nomdedéu
  • Resources and Services
    • Microarrays Unit
    • Cytogenetics Unit
    • Sample Handling Circuit Unit
    • Proteomics Unit
    • Genomics Unit
    • Bioinformatics Unit
    • Cell Immortalization Unit
    • Single Cell Unit
  • Training and Education
    • Work with us
    • INFANTLEUKEMIA
  • Our Supporters
    • Stakeholders
  • CatalàCA
  • EspañolES
  • EnglishEN
  • arAR
  • About Us
    • Who we are
      • Welcome
      • Scientific Founding Members
      • Director
      • Mission, Vision and Values
      • Governing bodies
        • Organizational chart
        • Board of Trustees
        • Management Committee
        • Internal Scientific Committee
        • Scientific Advisory Board (SAB)
        • Campus Coordinators
      • Why a Research Institute focusing on Leukaemia & other malignant blood diseases?
    • Directory
    • Research publications
    • How to find us
      • IJC Campus Clinic-UB
      • Campus ICO-Germans Trias i Pujol
      • Campus Sant Pau
    • Events Calendar
      • Showcasing Discoveries: Open Lectures of its Group Leaders
    • Contractors
    • Josep Carreras International Leukaemia Foundation
    • News & Press
      • News
    • Transparency Portal
    • HR Excellence
  • Research Groups
    • Cancer and Leukemia Epigenetics and Biology Program PEBCL
      • Cancer epigenetics - Manel Esteller
      • Cancer genetics - Montse Sanchez-Cespedes
      • Chromatin biology laboratory - Alex Vaquero
      • Chromatin, metabolism and cell fate - Marcus Buschbeck
      • 3D chromatin organization - Biola M Javierre
      • Epigenetics and immune disease - Esteban Ballestar
      • Lymphocyte development and disease - Maribel Parra
      • Regulatory genomics - Tanya Vavouri
      • Regulatory RNA and chromatin - Sonia Guil
      • Epigenetic control of haematopoiesis - José Luis Sardina
      • Transcriptional dynamics in leukemia - Sergi Cuartero
      • Cancer immunogenomics - Eduard Porta
      • Cancer heterogeneity and hierarchies - Verónica Rodilla
      • Leukemia and immuno-oncology - Laura Belver
      • Cellular systems genomics - Elisabetta Mereu
      • Stem cells and cancer - Anna Bigas
      • Endothelial pathobiology and microenvironment - Mariona Graupera
      • T cell lymphoma - Laura Mondragón
      • Nuclear Architecture in Leukemia - Gregoire Stik
      • Cancer Metabolism - Lucas Pontel
    • Experimental and Clinical Hematology Program PHEC
      • Acute lymphoblastic leukemia (ALL) - José María Ribera
      • Barcelona Endothelium Team (BET) - Enric Carreras
      • Myeloid neoplasms - Lurdes Zamora
      • Immunohematology and glycobiology - Fumiichiro Yamamoto
      • Lymphoid neoplasms - Tomás Navarro
      • Multiple myeloma - Albert Oriol
      • Myelodysplastic syndromes - Francesc Solé
      • Stem cell biology, developmental leukemia and immunotherapy - Pablo Menéndez
      • Stem cell transplantation and cellular Immunotherapy - Álvaro Urbano-Ispizua
      • Epigenetic therapies - María Berdasco
      • Lymphoma translational group - Gaël Roué
      • Oncogenesis and antitumor drugs - Ramon Mangues
      • Chronic lymphocytic leukemia - Carolina Moreno
      • Hematological diseases, transplant, and cell therapy - Jordi Sierra
      • Myeloid neoplasms - Clínic - Jordi Esteve Reyner
      • Hematology - David Gallardo
      • Descriptive epidemiology, genetics and cancer prevention - Rafael Marcos-Gragera
      • Cellular immunotherapy and gene therapy group - Javier Briones
      • Hematological diagnosis - Josep Nomdedéu
  • Resources and Services
    • Microarrays Unit
    • Cytogenetics Unit
    • Sample Handling Circuit Unit
    • Proteomics Unit
    • Genomics Unit
    • Bioinformatics Unit
    • Cell Immortalization Unit
    • Single Cell Unit
  • Training and Education
    • Work with us
    • INFANTLEUKEMIA
  • Our Supporters
    • Stakeholders
  • Who we are
  • Directory
  • Research publications
  • How to find us
  • Events Calendar
  • Contractors
  • Josep Carreras International Leukaemia Foundation
  • News & Press
  • Transparency Portal
  • HR Excellence
Nuri de Haro

Nuri De Haro

Position at Josep Carreras Institute:

Core Facility Technician

Contact:

ndeharo@carrerasresearch.org

Campus ICO-Germans Trias i Pujol

Germans Trias i Pujol logo

Josep Carreras Leukaemia Research Institute (IJC)
Ctra de Can Ruti,
Camí de les Escoles s/n
08916 Badalona, Barcelona - SPAIN
Tel: (+34) 93 557 2800
Fax: (+34) 93 465 1472

  • Twitter Logo
  • Linkedin logo

The IJC is a CERCA center.

  • English FIJC logo

Contact

  • Contact list icon

    List of Contacts

  • How to reach us icon

    How to reach us

  • Webmail
  • Site map
  • Legal notice
  • Accessibility

Sponsors

Generalitat de Catalunya logo
Universitat Autònoma de Barcelona logo
Universitat de Barcelona logo
Ajuntament de Badalona logo